# Peptides for women · PepVault guides

Source: https://pepvault.app/guides/peptides-for-women

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [The science](https://pepvault.app/guides#science)

# Peptides for women: what the trials in women show, and after 40

Reviewed November 2026 16 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

Which peptides were tested in women: semaglutide, tirzepatide, PT-141, GHK-Cu, collagen, BPC-157, tesamorelin and HGH, with how many women and what was found.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 16
- **Questions:** 8
- **Compounds:** 8

## The short answer

The peptides with solid data in women are the GLP-1s and bremelanotide. Women were 68 to 74% of the main semaglutide and tirzepatide trials, and where results were split by sex, women lost more weight than men. Vyleesi is approved only for premenopausal women. GHK-Cu and collagen have small skin trials in women, BPC-157 one 12-woman pilot, and tesamorelin and HGH were studied mostly in men.

Every number checked at its primary source · Nov 20, 2026 · [16 sources](https://pepvault.app/guides/peptides-for-women#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** Large randomized trials for semaglutide and tirzepatide (mostly women) and for bremelanotide (women only); for GHK-Cu, collagen and HGH, small randomized trials; for BPC-157, one uncontrolled pilot; tesamorelin's trials were mostly men.

## Which peptides have actually been tested in women?

Most lists of "peptides for women" name a dozen compounds and give no trial numbers. The table below does the opposite: for each compound women search, it shows what was studied, how many women were in the human studies, what was found, and how strong that evidence is. The labels and papers are current as of November 2026.

| Compound | What was studied | Women in the human studies | What was found | Evidence level |
| --- | --- | --- | --- | --- |
| Semaglutide (Wegovy) | Weight, 68 weeks (STEP 1) and 4 years (SELECT) | 74% of 1,961 adults in STEP 1[1](https://pepvault.app/guides/peptides-for-women#source-1); 27.7% of 17,604 in SELECT[3](https://pepvault.app/guides/peptides-for-women#source-3) | In SELECT at 2 years, women lost 11.1% more than placebo, men 7.5%[3](https://pepvault.app/guides/peptides-for-women#source-3) | Approved drug, large randomized trials |
| Tirzepatide (Zepbound) | Weight, 72 weeks (SURMOUNT-1) | 68% of 2,539 adults[2](https://pepvault.app/guides/peptides-for-women#source-2) | In a Mayo Clinic cohort of 1,039 (57% women), women lost 15.1% at 15 months, men 10.7%[4](https://pepvault.app/guides/peptides-for-women#source-4) | Approved drug, large randomized trials; the sex split comes from an observational clinic cohort |
| Bremelanotide (Vyleesi, PT-141) | Low sexual desire with distress, 24 weeks | 1,267 premenopausal women, mean age 39[6](https://pepvault.app/guides/peptides-for-women#source-6) | Desire score rose 0.35 points more than on placebo; nausea in 40%[6](https://pepvault.app/guides/peptides-for-women#source-6) [5](https://pepvault.app/guides/peptides-for-women#source-5) | Approved for premenopausal women only |
| GHK-Cu (on the skin) | Facial wrinkles, 8 weeks | 40 women aged 40 to 65, 39 finished[7](https://pepvault.app/guides/peptides-for-women#source-7) | Wrinkle volume fell 55.8% more than on a serum base without GHK-Cu[7](https://pepvault.app/guides/peptides-for-women#source-7) | One small randomized trial |
| Collagen peptides (by mouth) | Skin aging; bone density | 19 skin trials, 1,125 people, 95% women[8](https://pepvault.app/guides/peptides-for-women#source-8); 131 postmenopausal women[9](https://pepvault.app/guides/peptides-for-women#source-9) | Better hydration, elasticity and wrinkles[8](https://pepvault.app/guides/peptides-for-women#source-8); spine and hip bone density rose against placebo[9](https://pepvault.app/guides/peptides-for-women#source-9) | Several small randomized trials; one bone trial |
| BPC-157 | Bladder pain (interstitial cystitis) | 12 women aged 39 to 76[10](https://pepvault.app/guides/peptides-for-women#source-10) | 10 of 12 reported full relief after one treatment; no placebo group[10](https://pepvault.app/guides/peptides-for-women#source-10) | One uncontrolled pilot |
| Tesamorelin (Egrifta) | Belly fat in people with HIV, 26 weeks | 14 to 16% of 816 adults in two trials[12](https://pepvault.app/guides/peptides-for-women#source-12) | Visceral fat fell 15.4% against placebo, men and women pooled[13](https://pepvault.app/guides/peptides-for-women#source-13) | Approved drug for HIV; few women |
| HGH (somatropin) | Body composition in healthy older adults, 26 weeks | 57 women (and 74 men) aged 65 to 88[14](https://pepvault.app/guides/peptides-for-women#source-14) | Lean mass +1.0 kg against +0.4 kg on placebo; strength did not change[14](https://pepvault.app/guides/peptides-for-women#source-14) | One randomized trial that reports older women separately |

The pattern is plain. The two GLP-1s were tested in thousands of women, and Vyleesi was tested only in women. Everything else rests on a few dozen women each, or on trials that were mostly men.

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

PepVault keeps the weight log and the dose log side by side, with a reminder on dose day, so each step-up and its weight trend sit in one record.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Do women lose more weight on semaglutide and tirzepatide?

In the analyses that split results by sex, yes. In SELECT, a four-year semaglutide trial of 17,604 adults with heart disease, women had lost 11.1% more weight than women on placebo at two years, and men 7.5% more than men on placebo[3](https://pepvault.app/guides/peptides-for-women#source-3). In 1,039 Mayo Clinic patients who stayed on tirzepatide for at least a year, women lost 15.1% of their weight at 15 months and men 10.7%; female sex predicted more loss, and age did not once the other factors were counted[4](https://pepvault.app/guides/peptides-for-women#source-4). That second study is an observational cohort drawn from clinic records, not a randomized trial. Both labels state that weight fell irrespective of sex[1](https://pepvault.app/guides/peptides-for-women#source-1) [2](https://pepvault.app/guides/peptides-for-women#source-2).

One side effect also splits by sex. On Wegovy 2.4 mg, 4% of women and 0.9% of men reported hair loss (2% of women on placebo), and 8.4% of women on the newer 7.2 mg dose; on Zepbound, 7.1% of women and 0.5% of men (1.3% of women on placebo)[1](https://pepvault.app/guides/peptides-for-women#source-1) [2](https://pepvault.app/guides/peptides-for-women#source-2). Both labels tie it to the weight loss, and on Zepbound no one stopped treatment because of it[2](https://pepvault.app/guides/peptides-for-women#source-2). It is usually a temporary shed (the hair-loss guide covers why).

**Commonly reported:** women on a GLP-1 describe extra shedding in the brush or shower that starts a few months in and settles later, and an appetite that changes across the menstrual cycle in the first months.

- A weekly weigh-in shows your own curve against the trial numbers, which are averages at 68 to 72 weeks.
- A photo in the same light every month shows hair changes more fairly than memory.

<!--promo-->

PepVault keeps the weight log and the dose log side by side, with a reminder on dose day, so each step-up and its weight trend sit in one record. [Track your weight in PepVault](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-peptides-for-women-inline&mt=8)

<!--/promo-->

## What is PT-141 approved for in women?

Bremelanotide, sold as Vyleesi, is approved for premenopausal women with acquired, generalized low sexual desire that causes marked distress, and is not approved for postmenopausal women or men[5](https://pepvault.app/guides/peptides-for-women#source-5). In the two RECONNECT trials, 1,267 women were randomized, and desire rose 0.35 points more than on placebo on a scale that runs from 1.2 to 6[6](https://pepvault.app/guides/peptides-for-women#source-6) [5](https://pepvault.app/guides/peptides-for-women#source-5). Nausea was the most common effect, in 40% against 1.3% on placebo, and it improved for most women by the second dose[5](https://pepvault.app/guides/peptides-for-women#source-5). The PT-141 guide covers the trials in detail.

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Amino acid](https://pepvault.app/glossary/amino-acid)
- [Cycle](https://pepvault.app/glossary/cycle)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Growth hormone (GH)](https://pepvault.app/glossary/growth-hormone)
- [GHRH](https://pepvault.app/glossary/ghrh)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)

## Do GHK-Cu and collagen work on women's skin?

Both have small human trials, and the trials were mostly women. GHK-Cu is a copper-carrying peptide of three amino acids. In a double-blind split-face trial, 40 women aged 40 to 65 applied a GHK-Cu serum to one side of the face twice a day for 8 weeks, and either the serum base without GHK-Cu or a Matrixyl 3000 product to the other side; 39 finished. With about 20 women in each comparison, wrinkle volume fell 55.8% more on the GHK-Cu side than on the base, and 31.6% more than on Matrixyl 3000. The serum's maker funded the trial[7](https://pepvault.app/guides/peptides-for-women#source-7).

Collagen peptides are food protein cut into fragments and taken by mouth. A 2021 meta-analysis pooled 19 randomized trials with 1,125 people aged 20 to 70, 95% of them women, and found better skin hydration, elasticity and wrinkles than on placebo after about 90 days[8](https://pepvault.app/guides/peptides-for-women#source-8).

## Is there any BPC-157 data in women?

One small study, and it is all women. Twelve women aged 39 to 76 with interstitial cystitis, a long-term bladder pain condition, who had not responded to the approved drug, had BPC-157 injected around the inflamed area of the bladder in a single procedure. Ten of the 12 reported full relief and the other two 80%, and no side effects were reported[10](https://pepvault.app/guides/peptides-for-women#source-10). There was no placebo group. The other human reports are a review of 16 knee-pain patients' clinic charts, which gives no result by sex in its abstract[11](https://pepvault.app/guides/peptides-for-women#source-11), and a two-person intravenous safety pilot that included one woman, aged 68, with no side effects reported[16](https://pepvault.app/guides/peptides-for-women#source-16). No human study compares BPC-157 in women and men.

## Were women in the tesamorelin and HGH trials?

Few. Tesamorelin, a lab-made copy of the hormone that tells the pituitary to release growth hormone (GHRH), was tested in the two trials on its label, of 412 and 404 adults with HIV and excess belly fat, and 86% and 84% of them were men[12](https://pepvault.app/guides/peptides-for-women#source-12). Pooled, it cut visceral fat, the fat around the organs, 15.4% more than placebo over 26 weeks[13](https://pepvault.app/guides/peptides-for-women#source-13). A PubMed search found no published tesamorelin trial in women alone.

HGH has one well-known randomized trial that reports older women on their own. In its 57 healthy women aged 65 to 88 (the trial also enrolled 74 men), 26 weeks of growth hormone raised lean mass by 1.0 kg against 0.4 kg on placebo, and by 2.1 kg when combined with hormone therapy. Fat mass fell, but strength and fitness did not change significantly, and 39% of women on growth hormone had swelling against none on placebo[14](https://pepvault.app/guides/peptides-for-women#source-14). The Genotropin label adds that women with normal estrogen levels may need higher doses than men to reach the same treatment goal, and that oral estrogen can raise the dose a woman needs[15](https://pepvault.app/guides/peptides-for-women#source-15).

## Which peptides have data after 40 and after menopause?

Several of the trials above are trials of women past 40. The GHK-Cu trial enrolled women aged 40 to 65[7](https://pepvault.app/guides/peptides-for-women#source-7), the BPC-157 pilot women with a mean age of 58[10](https://pepvault.app/guides/peptides-for-women#source-10), and the HGH trial women aged 65 to 88[14](https://pepvault.app/guides/peptides-for-women#source-14). For menopause itself, the GLP-1s have the most data: the GLP-1s and menopause guide covers weight loss before, during and after menopause, hormone therapy and bone.

For bone, the clearest peptide trial is collagen. In 131 postmenopausal women with low bone density, mean age 64, a trial's 5 g of specific collagen peptides a day for 12 months raised the spine T-score by 0.1 while it fell 0.03 on placebo, and the hip (femoral neck) T-score by 0.09 against a fall of 0.01; 102 women finished, and all 131 were counted[9](https://pepvault.app/guides/peptides-for-women#source-9). A T-score compares bone density with a healthy young adult's. The changes are small, from one trial.

For muscle, the HGH trial is the caution: lean mass rose, strength did not[14](https://pepvault.app/guides/peptides-for-women#source-14). Vyleesi does not extend past menopause, since its label excludes postmenopausal women[5](https://pepvault.app/guides/peptides-for-women#source-5).

## What do the labels say about pregnancy and the pill?

Each approved peptide's label speaks to pregnancy directly. Here is what each says, in the labels' terms.

- Wegovy: stop at least 2 months before a planned pregnancy, because semaglutide stays in the body a long time, and stop when pregnancy is recognized[1](https://pepvault.app/guides/peptides-for-women#source-1).
- Zepbound: it may make birth-control pills less effective, because it slows how fast the stomach empties. Women on the pill switch to a non-pill method or add a barrier method for 4 weeks after starting and for 4 weeks after each dose increase; non-oral hormonal methods should not be affected. Stop when pregnancy is recognized[2](https://pepvault.app/guides/peptides-for-women#source-2).
- Vyleesi: use effective contraception while taking it, and stop if pregnancy is suspected[5](https://pepvault.app/guides/peptides-for-women#source-5).
- Egrifta WR: not to be used in pregnancy; stop it if pregnancy occurs[12](https://pepvault.app/guides/peptides-for-women#source-12).

Research peptides such as BPC-157 and GHK-Cu by injection have no pregnancy data at all. The GLP-1s and pregnancy guide covers the semaglutide and tirzepatide labels in full. When to stop before a planned pregnancy is your prescriber's call. If you find you are pregnant while taking one of these, stop as its label says and let them know that week.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. Novo Nordisk. WEGOVY (semaglutide) prescribing information, revised June 2026. DailyMed, SPL version 19. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
2. Eli Lilly. ZEPBOUND (tirzepatide) prescribing information, August 2026. DailyMed, SPL version 40. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)
3. Ryan DH et al. Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial. Nat Med. 2024. [PubMed 38740993](https://pubmed.ncbi.nlm.nih.gov/38740993/)
4. Castaneda R et al. Sex, not age, predicts weight loss outcomes with tirzepatide: a retrospective analysis. Obesity (Silver Spring). 2026. [PubMed 42290037](https://pubmed.ncbi.nlm.nih.gov/42290037/)
5. Cosette Pharmaceuticals. VYLEESI (bremelanotide) prescribing information. DailyMed, SPL version 2, November 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf)
6. Kingsberg SA et al. Bremelanotide for the treatment of hypoactive sexual desire disorder: two randomized phase 3 trials. Obstet Gynecol. 2019. [PubMed 31599840](https://pubmed.ncbi.nlm.nih.gov/31599840/)
7. Badenhorst T, Svirskis D, Merrilees M et al. Effects of GHK-Cu on MMP and TIMP expression, collagen and elastin production, and facial wrinkle parameters. J Aging Sci. 2016;4:166. [doi.org](https://doi.org/10.4172/2329-8847.1000166)
8. de Miranda RB, Weimer P, Rossi RC. Effects of hydrolyzed collagen supplementation on skin aging: a systematic review and meta-analysis. Int J Dermatol. 2021. [PubMed 33742704](https://pubmed.ncbi.nlm.nih.gov/33742704/)
9. König D et al. Specific collagen peptides improve bone mineral density and bone markers in postmenopausal women: a randomized controlled study. Nutrients. 2018. [PubMed 29337906](https://pubmed.ncbi.nlm.nih.gov/29337906/)
10. Lee E, Walker C, Ayadi B. Effect of BPC-157 on symptoms in patients with interstitial cystitis: a pilot study. Altern Ther Health Med. 2024. [PubMed 39325560](https://pubmed.ncbi.nlm.nih.gov/39325560/)
11. Lee E, Padgett B. Intra-articular injection of BPC 157 for multiple types of knee pain. Altern Ther Health Med. 2021. [PubMed 34324435](https://pubmed.ncbi.nlm.nih.gov/34324435/)
12. Theratechnologies. EGRIFTA WR (tesamorelin) prescribing information. DailyMed, SPL version 2, July 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75)
13. Falutz J et al. Effects of tesamorelin (TH9507) in HIV-infected patients with excess abdominal fat: a pooled analysis of two phase 3 trials with safety extension data. J Clin Endocrinol Metab. 2010. [PubMed 20554713](https://pubmed.ncbi.nlm.nih.gov/20554713/)
14. Blackman MR et al. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA. 2002. [PubMed 12425705](https://pubmed.ncbi.nlm.nih.gov/12425705/)
15. Pfizer. GENOTROPIN (somatropin) prescribing information. DailyMed, SPL version 37, August 2026. [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ffebf88b-d257-4542-9808-74d9b7167765)
16. Lee E, Burgess K. Safety of intravenous infusion of BPC157 in humans: a pilot study. Altern Ther Health Med. 2025. [PubMed 40131143](https://pubmed.ncbi.nlm.nih.gov/40131143/)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · GLP-1

Guide · GLP-1

### [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)

Does low-dose naltrexone cause weight loss? The human naltrexone weight trials in one table, with Contrave's label numbers and Wegovy and Zepbound beside them.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [Semaglutide Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/semaglutide)
- [Tirzepatide Studied range: 2.5–15 mg](https://pepvault.app/peptides/tirzepatide)
- [PT-141 Studied range: 0.5–2 mg](https://pepvault.app/peptides/pt-141)
- [GHK-Cu Studied range: 1–2 mg](https://pepvault.app/peptides/ghk-cu)
- [Collagen Peptides Studied range: 5–15 g](https://pepvault.app/peptides/collagen-peptides)
- [BPC-157 Studied range: 200–500 mcg](https://pepvault.app/peptides/bpc-157)
- [Tesamorelin Studied range: 1–2 mg](https://pepvault.app/peptides/tesamorelin)
- [HGH Studied range: 1–4 IU](https://pepvault.app/peptides/hgh)

## Related guides

- Guide · GLP-1s

  ### [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)

  What to expect on tirzepatide week by week: the label's dose steps, when appetite and nausea change, weight loss from week 20 to year 3, and the plateau.

  Read the guide
- Guide · Recovery

  ### [GHK-Cu for skin and hair: what's measured](https://pepvault.app/guides/ghk-cu-skin-and-hair)

  What GHK-Cu has shown in people for skin and hair: the serum and laser trials, the hair studies, what is lab-only, and what injecting it has never tested.

  Read the guide
- Guide · Recovery

  ### [BPC-157: the human data we have](https://pepvault.app/guides/bpc-157-human-data)

  Every published human study of BPC-157: the knee pain, bladder pain and IV safety pilots, what each found, the trials now registered, and how it works.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Can a GLP-1 cause low blood sugar if you do not have diabetes?](https://pepvault.app/guides/glp-1-low-blood-sugar)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Amino acid](https://pepvault.app/glossary/amino-acid)
- [Cycle](https://pepvault.app/glossary/cycle)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Growth hormone (GH)](https://pepvault.app/glossary/growth-hormone)
- [GHRH](https://pepvault.app/glossary/ghrh)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
